U.S., March 19 -- An application to own the trademark for 'BEXUMYCA' has been filed on Aug. 07, 2024.
Owner(s):
Faraday Pharmaceuticals, Inc.; 1616 Eastlake Avenue E, Suite 560, , Washington
Goods and/or Services:
For: Pharmaceutical preparations for the prevention and treatment of cardiac and skeletal muscle function diseases and disorders
Class(es): 005, 006, 018, 044, 046, 051, 052
For: Providing a website featuring information concerning medical diagnosis and treatment of cardiac and skeletal muscle function diseases and disorders
Class(es): 100, 101
For: Providing a website featuring information in the field of testing of pharmaceuticals; providing a website featuring information concerning medical research in the field of card...